BIOAVAILABILITY IN MAN OF MARKETED BRANDS OF CHLORPROPAMIDE

被引：16

作者：

MONRO, AM ^{[1
]}

WELLING, PG ^{[1
]}

机构：

[1] PFIZER LTD,CENT RES,DEPT DRUG METAB,SANDWICH,KENT,ENGLAND

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1974年 / 7卷 / 01期

关键词：

D O I：

10.1007/BF00614389

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：47 / 49

页数：3

共 10 条

[1]

BROTHERTON PM, 1969, CLIN PHARMACOL THER, V10, P505

[2]

CAMINETSKY S, 1963, CAN MED ASSOC J, V88, P950

[3]

CARMICHAEL RH, 1959, CLIN CHEM, V5, P597

[4]

CARTER AK, 1963, CAN MED ASSOC J, V88, P98

[5] DETERMINATION OF TOLBUTAMIDE AND CHLORPROPAMIDE IN BIOLOGICAL-FLUIDS [J].

MATIN, SB ;

ROWLAND, M .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (02) :186-188

[6] GAS-LIQUID CHROMATOGRAPHIC ESTIMATION OF TOLBUTAMIDE AND CHLORPROPAMIDE IN PLASMA [J].

PRESCOTT, LF ;

REDMAN, DR .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1972, 24 (09) :713-&

[7] GAS CHROMATOGRAPHIC METHOD FOR DETERMINATION OF TOLBUTAMIDE AND CHLORPROPAMIDE [J].

SABIH, K ;

SABIH, K .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1970, 59 (06) :782-&

[8]

TAYLOR JA, 1972, CLIN PHARMACOL THER, V13, P710

[9] THE PHYSICAL PROPERTIES OF CHLORPROPAMIDE AND ITS DETERMINATION IN HUMAN SERUM [J].

TOOLAN, TJ ;

WAGNER, RL .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1959, 74 (03) :449-458

[10] GENERIC INEQUIVALENCE OF DRUGS [J].

VARLEY, AB .

JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1968, 206 (08) :1745-&

← 1 →